These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 25903466)

  • 21. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.
    Yin J; Hou P; Wu Z; Wang T; Nie Y
    Tumour Biol; 2015 Jun; 36(6):4501-7. PubMed ID: 25618599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.
    Guo X; Lv X; Lv X; Ma Y; Chen L; Chen Y
    Oncotarget; 2017 Jul; 8(27):44050-44058. PubMed ID: 28477010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.
    Liu Y; Ren F; Luo Y; Rong M; Chen G; Dang Y
    Med Sci Monit; 2015 Aug; 21():2352-60. PubMed ID: 26263159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma.
    Shen X; Xue Y; Cong H; Wang X; Ju S
    Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    Song SK; Jung WY; Park SK; Chung CW; Park Y
    PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
    Yoon EL; Yeon JE; Ko E; Lee HJ; Je JH; Yoo YJ; Kang SH; Suh SJ; Kim JH; Seo YS; Yim HJ; Byun KS
    J Korean Med Sci; 2017 Feb; 32(2):212-220. PubMed ID: 28049231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
    An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
    World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
    Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
    Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.